Hämatologie und Onkologie Berlin Mitte

Industry / private company


Location: Berlin, Germany (DE) DE

MoReLife – real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients (2024) Jilg S, Schwaab J, Sockel K, Crodel CC, Brückl V, Stegelmann F, Jentzsch M, et al. Journal article